Salvage therapy with pegylated liposomial doxorubicin-based regimen in relapsed/refractory multiple myeloma: comments to the article by Romano et al.

MLA

Cerchione, Claudio, et al. “Salvage Therapy with Pegylated Liposomial Doxorubicin-Based Regimen in Relapsed/Refractory Multiple Myeloma: Comments to the Article by Romano et Al.” European Journal of Haematology, vol. 96, no. 5, May 2016, p. 544. EBSCOhost, https://doi.org/10.1111/ejh.12705.

APA

Cerchione, C., Lucignano, M., Pane, F., & Catalano, L. (2016). Salvage therapy with pegylated liposomial doxorubicin-based regimen in relapsed/refractory multiple myeloma: comments to the article by Romano et al. European Journal of Haematology, 96(5), 544. https://doi.org/10.1111/ejh.12705

Chicago

Cerchione, Claudio, Mariano Lucignano, Fabrizio Pane, and Lucio Catalano. 2016. “Salvage Therapy with Pegylated Liposomial Doxorubicin-Based Regimen in Relapsed/Refractory Multiple Myeloma: Comments to the Article by Romano et Al.” European Journal of Haematology 96 (5): 544. doi:10.1111/ejh.12705.